Results 31 to 40 of about 62,368,048 (338)

Responding to the economic crisis: A question of law, policy or politics [PDF]

open access: yes, 2008
Introduction: I have been asked to consider the role of the law in the fallout from the financial and economic crisis that by the end of 2007 had become the problem but turned into a crisis by the end of 2008.
Wilson, Margaret
core   +1 more source

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

From What to How: An Initial Review of Publicly Available AI Ethics Tools, Methods and Research to Translate Principles into Practices

open access: yesScience and Engineering Ethics, 2019
The debate about the ethical implications of Artificial Intelligence dates from the 1960s (Samuel in Science, 132(3429):741–742, 1960. https://doi.org/10.1126/science.132.3429.741; Wiener in Cybernetics: or control and communication in the animal and the
J. Morley   +3 more
semanticscholar   +1 more source

Research (and researchers') data

open access: yes, 2023
Research data and data about researchers: can there be islands in the ocean of surveillance capitalism?
openaire   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

*Entrepreneurship and Dynamic Capabilities: A Review, Model and Research Agenda

open access: yes, 2006
The emergent literature on dynamic capabilities and their role in value creation is riddled with inconsistencies, overlapping definitions, and outright contradictions.
S. Zahra, H. Sapienza, P. Davidsson
semanticscholar   +1 more source

The Use of Cronbach’s Alpha When Developing and Reporting Research Instruments in Science Education

open access: yesResearch in Science Education, 2017
Cronbach’s alpha is a statistic commonly quoted by authors to demonstrate that tests and scales that have been constructed or adopted for research projects are fit for purpose. Cronbach’s alpha is regularly adopted in studies in science education: it was
K. Taber
semanticscholar   +1 more source

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait   +23 more
wiley   +1 more source

Corporate environmental assessment by a bank lender : a social constructionist perspective [PDF]

open access: yes, 2001
Over the last decade evidence has emerged which suggests that lenders are considering environmental impact of corporate borrowers as part of their lending decisions. Environmental consideration by lenders may considerably influence the level of financial
Coulson, A.B.   +1 more
core   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy